Janssen

RISPERDAL CONSTA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Janssen

Risperdal Consta HCPCS:

J2794

HCPCS Code Descriptor:

Injection, risperidone (risperdal consta), 0.5 mg

Category:

J Code

Risperdal Consta NDCs:

50458-0308-11, 50458-0306-11, 50458-0307-11, 50458-0309-11, 00480-1342-08, 00480-1453-08, 00480-1232-08, 00480-1554-08

Primary Type:

Psychiatric

Generic/Specialty Status:

Single-Source

Package Type:

Box

Route of Administration:

Intramuscular

Risperdal Consta CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Risperdal Consta:

RISPERDAL CONSTA is a Psychiatric drug manufactured by Janssen and administered via the Intramuscular route of administration. The J Code: J2794 is aligned to the drug RISPERDAL CONSTA.

Risperdal Consta is an injectable medication used to treat schizophrenia in adults. It is long-lasting and belongs to a class of medications called atypical antipsychotics. It may be used alone, or in combination with lithium or valproate to help treat patients with bipolar disorder. Risperdal Consta is thought to work by altering the activity of certain substances within the brain.

ACCESS PRICING AND MORE BY REGISTERING

J2794 Added Date:

January 1, 2005

J2794 Effective Date:

October 1, 2019

J2794 Termination Date:

HCPCS Active

Risperdal Consta billing and coding information can be found through Janssen at the link below:
Risperdal Consta patient assistance information can be found through the Johnson and Johnson Patient Assistance Foundation at the URL: http://www.jjpaf.org/
RISPERDAL CONSTA prescribing information can be found at the link below:
Information regarding RISPERDAL CONSTA’s side effects can be found at MedlinePlus